Cube Labs Portfolio Holdings Valued at EUR 96.95 Million on Average
Cube Labs published a EUR 96.95 million portfolio valuation dated December 31, 2025; Adamas Biotech reported positive IBS-C trial results. Bio Aurum extended its trial through fourth-quarter 2026; Biodiapers secured European and Indian patents; Cartilago advanced preclinical planning. Crati River Valley sought developm